Abstract. Despite ongoing developments of treatment protocols head and neck squamous cell carcinomas (HNSCC) show only marginal improvement in outcome, which has been attributed to a lack of therapy individualized to tumor biological properties. We compared mRNA expression profiles of HNSCC and normal epithelial cells using differential display to identify gene fragments showing differential expression in HNSCC cells. We identified a 127-bp long fragment to be overexpressed in HNSCC cells that revealed a 98.4% homology with the Pim-1 mRNA. The differential expression was confirmed by Northern hybridization. Immunohistochemistry showed overexpression of the Pim-1 protein in 98% (41/42) of invasive HNSCC. Analysis of Pim-1 protein expression in relation to TNM stage and histological grade of the tumors exhibited no significant correlation. However, when samples of primary tumor and metastasis retrieved from the same patients (n=26) were analyzed, nearly significant correlation of Pim-1 expression with histological grade was found (p=0.06). The high frequency of the Pim-1 expression of HNSCC of different grades and stages in conjunction with its absence in non-neoplastic head and neck squamous cell epithelium underlines the functional role of Pim-1 in molecular processes of HNSCC.
Introduction
Head and neck squamous cell carcinomas (HNSCC) are characterized by aggressive growth and early metastatic spread (1) . Despite ongoing developments in tumor surgery as well as radio-and chemo-therapy, HNSCC survival remains largely unimproved (2) . A part of this problem is thought to be the lack of individualization of radio-and chemo-therapy regimens based on tumor biological properties (3) , which emphasizes the importance of ongoing molecular genetic studies to define alterations in gene expression that may potentially help to predict tumor behavior and guide therapy more effectively (4) . Furthermore, alterations in gene expression are the first detectable step of malignant transformation and can therefore be visualized long before histologic or macroscopic changes become apparent, which also bears the potential of a diagnostic advantage (5) . Until now, numerous genes have been associated with HNSCC, including p53, and c-myc (6, 7) . Differential display (DD)RT-PCR is capable of assessing 95% of the eukaryotic mRNA, and therefore suitable to distinguish benign and malignant genotypes based on their mRNA expression profiles, which allows the identification of differentially expressed gene transcripts and the subsequent isolation and sequencing of them (8) . In this report we present Pim-1 overexpression in HNSCC. Pim-1 is a 5.22-kb long protooncogene located on chromosome 6p21.2 that codes for 33-kDa (cytosolic/nucleic) and 44-kDa (submembraneous) variants of an ubiquitous intracellular enzyme (EC 2.7.11.1), which are capable of serine and threonine phosphorylation (9, 10) . The two isoforms are separated by an alternative translational initiation site (11) . Recently, Chiang et al reported Pim-1 upregulation in oral cancer squamous cell cancer formation (12) , suggesting an involvement in HNSCC carcinogenesis.
Materials and methods
Cell cultures. For the DDRT-PCR procedure, two wellcharacterized cell lines, i.e. University of Michigan squamous cell carcinoma (UMSCC)-10A and University of Turku squamous cell carcinoma (UTSCC)-19A were utilized. Two keratinocyte cultures derived from pharyngeal and oral mucosa were used as control. The carcinoma cells were cultivated in Dulbecco's modified Eagle's medium, supplemented with L-glutamine, 2.5 mg/ml Amphotericin B, 10% (v/v) fetal bovine serum (Seromed, Berlin, Germany), 20 U/ml penicillin, and 20 mg/ml streptomycin. The normal keratinocytes were grown in serum-free medium (Promocell, Heidelberg, Germany). The pH of the medium was adjusted to 7.4 by adding 0.1 N sodium hydroxide. The cultures were incubated at 37˚C in a 5% CO 2 humidified atmosphere.
Histology samples. Forty-two carcinoma samples were retrieved during surgery. In addition, five normal mucosa samples (three nasal mucosa and two tonsillar epithelium) were collected to serve as controls. All samples were retrieved during surgery at the Department of Otorhinolaryngology at the University of Schleswig-Holstein, Campus Kiel, Germany, following informed consent approved by the local ethics committee (AZ:D413/03). The 42 tumor samples were derived from 28 patients (78.5% male, mean age: 67.39±9.49 years), with 19 primary tumor and 23 metastasis samples. The control samples were taken during regular surgical treatment without additional excisions. Specimen characterization and histological grading are summarized in Table I .
Isolation of total RNA. For rapid and reproducible preparation of the RNA, the TRIzol ® total RNA kit (Gibco, Ingolstadt, Germany) was used according to the manufacturer's instructions. After measurement of the RNA concentration, samples were adjusted to 1 μg/μl for subsequent first-strand cDNA synthesis. Quantitative analysis of the mRNA content was performed by RT-PCR using glyceraldehyde-3-phosphate dehydrogenase (G3PDH) as a control.
First-strand cDNA synthesis. Total RNA was heat denaturated (70˚C, 10 min), chilled on ice, and subjected to oligo(dT)-primed reverse transcription using a first-strand cDNA synthesis kit (Gibco). Reverse transcription was conducted with 300 U of MMLV reverse transcriptase in the presence of 20 μM dNTP, and 2.5 μM T 11 NM oligonucleotide, with N representing any base of cytosine, guanine and adenine, and M representing any base of cytosine, guanine, adenine, and thymine. The reagents were treated by 37, 44 and 70˚C cycles lasting for 15, 45 and 15 min, respectively. The resulting heat denaturated single-strand cDNA was subjected to amplification.
Differential display.
Complementary DNA was incubated with 0.5 μM of one of the arbitrary primer set (MWG-Biotech, Ebersberg, Germany), 2.5 μM of the corresponding anchored oligo(dT)-primer, 2.5 μM dNTPs, 1.5 μM MgCl 2 , 2 μCi [α-33 P]-dATP (Amersham, Braunschweig, Germany), and 2.5 U Taq-polymerase in a final volume of 50 μl. Lowstringency PCR was carried out after initial heat degradation for 40 cycles at 94˚C for 30 sec, 42˚C for 60 sec, and 72˚C for 30 sec, with a final extension step at 72˚C for 5 min (Thermocycler 9600; Perkin-Elmer, Norwalk, CN, USA). After thermocycling the samples were mixed with 11 μl loading dye (97% deionized formamide, 10 mM EDTA, 0.1% xylene cyanol, 0.1% bromphenol blue) each, and incubated by 80˚C for 2 min. Subsequently, 5 μl of the mixture was loaded on a 6% urea containing denaturizing polyacrylamide sequencing gel. Electrophoresis was carried out for ~100 min with 40 W constant power until the xylene dye was ~1 cm to the bottom. After electrophoresis, the gel was dried, and autoradiographed. The orientation of the autoradiograph was provided by a marking on both the X-ray film and the paper sheet carrying the gel.
Isolation, re-amplification, and cloning of cDNA. After developing the film bands of interest were located in the gel by punching the film with a needle. The gel slices, along with the paper, were soaked in 100 μl H 2 O for 10 min, boiled for 15 min, and centrifuged at 10,000 x g for 2 min. The supernatant was transferred to a new microfuge tube, treated with 10 μl of 3 M NaOAc, 5 μl of 10 mg/ml glycogen, 450 μl of 100% ethanol and incubated at -80˚C for 30 min. The sample was centrifuged at 4˚C for 10 min to sediment the DNA. After removing the supernatant, DNA was rinsed with ice-cold 85% ethanol and centrifuged again. The pellet was dissolved with 10 μl of H 2 O and 4 μl was subjected to re-amplification under the same conditions as mentioned above, except that no isotopes were added. Following routine procedures, 5 μl of the 40 μl re-amplified products was separated in 1% agarose gel and stained with 0.01% ethidium bromide. Purified double-stranded cDNA fragments were ligated into the pGEM-T ® vector (Promega, Heidelberg, Germany), and cloned. The plasmid-DNA was extracted using the Plasmid Mini Kit (Qiagen, Hilden, Germany) for purification according to the manufacturer's instructions. The ligation was checked by restriction analysis and subsequent agarose gel electrophoresis.
Analytical high-stringency nested PCR and sequencing of the cDNA. The recombinant plasmids were prepared for cyclesequencing by PCR using Dye Terminator (Perkin-Elmer, Weiterstadt, Germany) in a total volume of 50 μl. The reaction mixture contained 5 μl 10X buffer, 2.5 U Taq-polymerase, 0.2 mM of each dNTP, 1.5 mM MgCl 2 , and 0.1 μmol of forward (5'-G TAA AAC GAC GGC CAG-3') and reverse (5'-CAG GAA ACA GCT ATG AC-3') M13 primers (Promega) specific to the pGEM-T vector. The PCR was run for 30 cycles at 94˚C for 45 sec, 55˚C for 30 sec, and 72˚C for 90 sec, followed by a 3.5-min extension at 72˚C. After PCR, the amplicons were sequenced on a DNA-sequencing apparatus ABI PRISM 310 (Applied Biosystems, Weiterstadt).
Northern hybridization. In order to substantiate the DDRT-PCR findings, a confirmatory high-stringent RT-PCR with Pim-1 gene specific primers was conducted using 5'-CAA CGA CCT GCA ACG CCA C-3' as the sense and 5'-AGA GAC CCT CTG CCT GAA G-3' as the antisense primer. The probe was labeled by chemiluminescence (Boehringer, Mannheim, Germany). Subsequently, 20 μg heat-denaturated RNA derived from the HNSCC samples and keratinocytes underwent Northern blotting (13) . A G3PDH probe was used to enable comparison between the Pim-1 mRNA expression levels. Finally, the blots were exposed to an X-ray film (2-20 min) using an intensifier screen and processed for densitometric evaluation of the signals.
Immunohistochemistry. The tissue samples mentioned above were placed in 10% neutral buffered formalin immediately after they were obtained and were allowed to fix for 24-48 h. After fixation, the samples were dehydrated and embedded Table I . Immunohistochemical detection of Pim-1 in head and neck carcinomas. Normal mucosa -
a I, well differentiated; II, moderately differentiated; III, poorly differentiated. The expression of Pim-1 was determined by immunocytochemistry and estimated in range from -(no expression) to +++ (strong expression). CUP, carcinoma of unknown primary. n/a, not applicable.
- ---------------------------------------------------------------------------------------------------- in methylmethacrylate plastic. After polymerization, the samples were cut on a plane right-angled to the tissue surface. Longitudinal sections of 4 μm were cut with a rotary saw microtome and transferred onto a microscopic slide. For immunohistochemical examination, sections of tissue were deparaffinized in four cycles of Xylol for 10 min each. The samples were rehydrated in aqua dest for 10 min. Antigen retrieval was accomplished by washing the samples with Tris-buffered saline (TBS) solution for 5 min. Endogenous peroxidase was blocked for 30 min with 1% hydrogen peroxide in methanol. Non-specific immunoglobulin binding was blocked by incubation of the slides for 10 min with a 3% goat serum in TBS for 20 min. Primary affinity purified polyclonal rabbit anti-Pim-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added to the slides for 60 min at room temperature followed by incubation with a biotin-conjugated swine anti-rabbit IgG secondary antibody (Dako, Hamburg, Germany) at room temperature for 1 h. A labeled peroxidase complex system (ABC-Vectorstatin, Dako) was used to visualize all immune reactions. Sections were counterstained with Mayer's hematoxylin. For negative controls, the primary antibodies were replaced with homologous non-immune sera. The slides were evaluated in cooperation with the Pathology department of the University of SchleswigHolstein, Campus Kiel. To quantify the Pim-1 expression, 300 cells were examined in at least five areas at magnification x400 and a mean percentage of positive tumor cells was determined assigning cases to one of the four following categories: -, <5%; I, 5-30%; II, 31-75%; III, >75%. Cases with a score of -were considered as negative, cases with scores I, II, III were considered as positive.
Statistical analysis. All data assembled in this study were analyzed using SPSS 12.0 (Statistical Package for the Social Sciences, SPSS Inc., Chicago, IL). All results were tested on normal distribution using the Kolmogorov-Smirnov test. All normally distributed data are displayed as mean ± standard deviation, the non-normally distributed are displayed as median with 1st and 3rd quartile. We analyzed correlations between Pim-1 expression on the histology slides with TNM stage and histologic grade. If the data followed normal distribution, Pearson's bivariate correlation analysis was applied, if otherwise, Spearman's correlation analysis was used. A p<0.05 was considered significant.
Results
Differential expression of the Pim-1 mRNA. Three downstream primers (D2, D3, D4) were combined with 26 upstream primers, leading to 78 PCR investigations. The amplification products were separated by polyacrylamide gel electrophoresis, displaying ~80-100 individual cDNA bands per line, which in vast majority were identical in expression pattern. However, the combination of the D4 (5'-TTT TTT TTT TT AG-3') and U23 (5'-GAT CTG ACT G-3') primers showed reproducible differences between the cell lines' expression patterns, suggesting the presence of a differentially expressed gene (Fig. 1A) . The bands of interest were marked on the dried polyacrylamide gel with the help of an X-ray. Subsequently the fragment was recovered from the gel, re-amplified showing an ~130-bp long fragment and cloned (Fig. 1B and C) . After sequencing the cloned fragment the sequence was subjected to GenBank database searching with query sequences. A 98% identity with bases 5828-5955 belonging to the last exon (exon 6) of the human Pim-1 oncogene was found (Fig. 2) , with one additional guanine and adenine at positions 5854/5855 and 5867/5868 respectively.
Ligation, transformation and cloning. The amplified fragment was successfully ligated into a pGEM-T vector carrying ampicillin resistance and transformed into competent Escherichia coli. The Escherichia coli were cultivated on an ampicillin bearing medium, thereby selecting these cells with successful transformation. Ligation was verified via galactosidase inactivation in the plasmid. Following bacterial replication, the competent cells were lysed and the plasmids carrying the fragment isolated. Subsequently, the replicated fragment was cut out of the plasmid by restriction endonucleases and separated from the plasmid by agarose gel electrophoresis (Fig. 1C) .
Sequence analysis. For sequence analysis, competent cells were harvested and the plasmids isolated. The plasmids were then processed with vector-specific upstream and downstream primers. Sequence analysis of both amplicons in 5'-3' as well as 3'-5' direction identified a 127-bp long fragment that revealed a 98.4% homology with the Pim-1 mRNA (Fig. 2) . The human Pim-1 gene consists of 6113 bp. We identified our fragment in between base 5828 and 5955, with one additional guanine (5854/5855) and one additional arginine (5867/5868).
Northern hybridization. In order to substantiate DDRT-PCR findings, a confirmatory high-stringent RT-PCR with Pim-1 specific oligonucleotides was carried out. The gene deduced amplification product was 729-bp long, matching to the positions 73-802 of the Pim-1 mRNA. The overexpression of Pim-1-mRNA could be verified in HNSCC cells by using Northern analysis. The distinct band of 2.5 kb that corresponds to the estimated size of Pim-1-mRNA (2521 bp) clearly exhibited a higher excess in carcinoma cells as compared with normal epithelial cells (Fig. 1D) .
Pim-1 protein expression.
To assess the expression of the Pim-1 protein, immunohistochemistry was performed, using antibody raised against amino acids 271-313 mapping at the C-terminus of Pim-1 of human origin with both 33-and 44-kDa isoforms (Fig. 3) . Strong expression of Pim-1 in primary tumors (Fig. 3A) and metastases (Fig. 3B) was shown, the staining reaction being diffuse cytoplasmic. Normal non-neoplastic tonsillar epithelium (Fig. 3C ) and nasal mucosa (Fig. 3D ) exhibited virtually no reactivity with the Pim-1 antibody. Of the 42 tumor biopsies representing different locations and tumor stages, immunohistochemistry showed Pim-1 expression in 41 (98%) invasive HNSCC. The correlation between TNM and Pim-1 expression was not significant (p=0.15 for tumor stage; p=0.70 for nodal stage; and p=0.52 for metastasis stage, respectively). Similarly, Pim-1 expression appeared unrelated to the degree of tumor differentiation (p=0.08). In contrast, nearly significant correlation of Pim-1 expression with histological grade was found (p=0.06) when samples of primary tumor and metastasis retrieved from the same patients were analyzed (Table II) .
Discussion
The Pim-1 oncogene was originally identified as a common integration site for Moloney murine leukemia virus (14) , and was shown to efficiently cooperate with c-myc, N-myc, or bcl-2 genes in lymphomagenesis (15) . Pim-1 is involved in normal lymphocyte activation and proliferation (16) , and has been described to inhibit apoptosis (17) , which has given support to the potential involvement of Pim-1 in carcinogenesis, which has been well studied especially in prostate cancer (18) and lymphomas (19) .
Pim-1 regulation. The Pim-1 enzyme is controlled on transcriptional and posttranscriptional, as well as on translational and posttranslational levels (20) . Nagarajan et al suggested that Pim-1 mRNA expression is induced by reciprocal translocations involving 6p21 (21) , which is consistent with the observation that deletions of the short arm of chromosome 6 are frequently associated with lymphatic malignancies (22) . However, this approach is controversial, as von Lindern et al showed that induction of Pim-1 expression is not mediated via translocation as it is still located on chromosome 6 with the breaking point being 165 kb away (23) . The Pim-1 promoter contains no TATA and CAAT binding sites, but numerous GC boxes (24) . Hoover et al showed that in T lymphocytes, overexpressed Pim-1 mRNA did not correlate with the protein level due to a 400-bp non-translating GC-rich region within the mRNA (25) . Our results confirmed however, that increased Pim-1 mRNA expression was associated with an increased Pim-1 protein production.
Mechanisms of Pim-1-mediated carcinogenesis. Among the reported mechanisms of Pim-1-mediated cellular proliferation, the promotion of the complex formation between NuMA, HP1ß, dynein and dynactin is necessary for mitosis (26) . Furthermore, Pim-1 directly binds to a specific domain of tyrosine kinase and such interaction modulates the tyrosine kinase activity possibly by competing with the tumor suppressor p53 (27) . A major area of interest is the influence of Pim-1 on apoptosis. Wang et al showed that Pim-1 functions to prevent premature onset of apoptosis in myeloid cell differentiation due to tyrosine phosphatase inactivation (20) . Furthermore, Pircher et al showed suppression of Co60-and adriamycininduced apoptosis in murine hematopoetic cells (28) . Rahman et al demonstrated that Pim-1 expression is interleukin-6 dependent; once interleukin-6 is withdrawn, Pim-1 expression declines, leading to a higher rate of apoptosis in mouse B-cell hybridoma cells (29) . Another pathway considered was facilitation of tumor invasiveness and metastasis formation. Our own data did not show significant associations with either TNM state or the histological grade, and therefore does not support such an association, which is consistent with the literature on prostate cancer (18) . In consideration of our own data and the present literature, increased Pim-1 transcription and translation can fit well into several molecular cancer hallmarks proposed by Hanahan and Weinberg (30) , namely apoptosis evasion, resistance to growth inhibition, and growth promotion. Therefore, overexpressed Pim-1 might lead to malignant phenotypes via these mechanisms in HNSCC. Table II . Correlation of Pim-1 expression with clinical parameters. ----------------------------------------------------------------------------------------------------- PC, Pearson's correlation coefficient; p, p-value; N, number of pairs.
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